Les perturbateurs hormonaux coutent des milliards en Europe

Des produits chimiques industriels communs qui perturbent les hormones humaines et causent des dégâts de santé pourraient coûter à l’Europe plus de 110 milliards de livres par an, selon une étude.

Des produits chimiques industriels communs qui perturbent les hormones humaines et causent des dégâts de santé pourraient coûter à l’Europe plus de 110 milliards de livres par an, selon une étude.

Lisez la suite en anglais

Common industrial chemicals that disrupt human hormones and damage health could be costing Europe more than £110 billion a year, according to a study.
The international team behind the research presented their findings at the annual meeting of the Endocrinology Society in Brussels. They said their estimates on the high economic impact of chemicals in products including pesticides, plastics and flame retardants were “conservative.” The findings were published online on 5 March 2015 in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism.
EDCs have been implicated in the higher breast cancer rates found in workers in a range of industries including agriculture, plastics, food packaging, metal manufacture and the bar and gambling industries.
Leonardo Trasande, R Thomas Zoeller, Ulla Hass and others. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union, Journal of Clinical Endocrinology and Metabolism, published online 5 March 2015.